Theresa I Shireman
Affiliation: University of Kansas
- Relationship between asthma drug therapy patterns and healthcare utilizationTheresa I Shireman
Pharmacy Practice Department, School of Pharmacy, University of Kansas, Lawrence, KS 66045 7582, USA
Ann Pharmacother 36:557-64. 2002..The purpose of this study was to link inappropriate asthma drug therapy patterns and selected patient demographics to healthcare utilization...
- Medicaid managed care prescription use and cost savingsTheresa I Shireman
School of Pharmacy, University of Kansas, Lawrence 66045 7582, USA
J Am Pharm Assoc (Wash) 42:587-93. 2002..To evaluate the impact of Medicaid managed care (MC) enrollment on prescription use and costs...
- Patterns of antidepressant use among children and adolescentsTheresa I Shireman
Pharmacoeconomics, Pharmacy Practice Department, University of Kansas School of Pharmacy, Lawrence 66045, USA
Psychiatr Serv 53:1444-50. 2002..The purpose of this study was to identify patterns of new antidepressant use among children and adolescents and to determine whether the duration of treatment was sufficient...
- Quality of diabetes care for adults with physical disabilities in KansasAmanda Reichard
Research and Training Center on Independent Living, University of Kansas, Lawrence, KS 66044, USA
Disabil Health J 5:34-40. 2012..Similar to health disparities found among racial and ethnic minority groups, individuals with physical disabilities experience a greater risk for diabetes than those without disabilities...
- Heart failure drug utilization patterns for Medicaid patients before and after a heart failure-related hospitalizationPatricia A Howard
Department of Pharmacy Practice, University of Kansas School of Pharmacy, University Medical Center, 3901 Rainbow Boulevard, Lawrence, KS 66160 7231, USA
Congest Heart Fail 11:124-8. 2005..ACE inhibitors and vasodilator use remained constant. ACE-inhibitor doses were below target ranges before and after hospitalization. In this Medicaid cohort, HF-related hospitalizations did not lead to improved HF therapy...
- The cost effect of newer medication adoption in an older Medicaid cohortTheresa I Shireman
Pharmacy Practice Department, School of Pharmacy, University of Kansas, Kansas City, Kansas 66045, USA
J Am Geriatr Soc 53:1366-73. 2005..This article demonstrates how the adoption of newer drugs across diverse therapeutic classes contributed to one state's Medicaid expenditures over a 3-year period...
- Patterns of potentially inappropriate medication use across three cohorts of older Medicaid recipientsSally K Rigler
Department of Medicine, Research Faculty, Landon Center on Aging, School of Medicine, University of Kansas, Kansas City, KS 66160 7117, USA
Ann Pharmacother 39:1175-81. 2005..Potentially inappropriate medication use is a serious quality concern, especially when it occurs in more vulnerable older adults or for extended durations...
- Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellersCarolyn M Jachna
Division of General and Geriatric Medicine, Department of Internal Medicine, University of Kansas, Kansas City, Kansas, USA
J Am Geriatr Soc 53:1275-81. 2005..Little is known about differences between current patterns of antiresorptive therapy (ART) use in nursing facility (NF) residents and by community-dwelling older adults (CDs). ART use was compared in older NF residents and CDs...
- Medicaid's expenditures for newer pharmacotherapies for adults with disabilitiesTheresa I Shireman
University of Kansas, Medical Center, Department of Preventive Medicine and Public Health, KS 66160, USA
Health Care Financ Rev 28:31-41. 2007....
- Fracture risk in nursing home residents initiating antipsychotic medicationsSally K Rigler
Department of Medicine and, School of Medicine, University of Kansas, Kansas City, Kansas 66160, USA
J Am Geriatr Soc 61:715-22. 2013....
- Psychotropic medication use among Kansas Medicaid youths with disabilitiesTheresa I Shireman
University of Kansas School of Pharmacy and Landon Center on Aging, Lawrence, Kansas 66045 7582, USA
J Child Adolesc Psychopharmacol 15:107-15. 2005..Future work should explore the appropriateness and effectiveness of these medications within specifically targeted subgroups...
- Impact and cost-effectiveness of respiratory syncytial virus prophylaxis for Kansas medicaid's high-risk childrenTheresa I Shireman
Department of Pharmacy Practice, University of Kansas School of Pharmacy, 1251 Wescoe Hall Dr, Lawrence, KS 66045 7582, USA
Arch Pediatr Adolesc Med 156:1251-5. 2002..To determine the impact of prophylactic therapy for respiratory syncytial virus (RSV) infections on subsequent hospitalizations and related lengths of stay and costs and to estimate whether prophylactic treatment was cost-effective...
- Penny wise, pound wise: a comparison of Medicaid expenditures for home and community-based services versus nursing facility care for older adultsTheresa I Shireman
Center on Aging, University of Kansas, 1251 Wescoe Hall Drive, Room 6050, Lawrence, KS 66045, USA
Home Health Care Serv Q 23:15-28. 2004..Since NH and FE populations are dissimilar, these care options may not be easily interchangeable at the individual level...
- Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patientsTheresa I Shireman
Pharmacy Practice Department, University of Kansas School of Pharmacy, 1251 Wescoe Hall Drive, Lawrence, KS 66045, USA
Stroke 35:2362-7. 2004..Bleeding risks from combined antiplatelet-warfarin therapy have not been well-described in clinical practice. We examined antiplatelet therapy among warfarin users and the impact on major bleeding rates...
- Patterns of ACE inhibitor use in elderly medicaid patients with heart failurePatricia A Howard
University of Kansas School of Pharmacy, Department of Pharmacy Practice, Lawrence, USA
Am J Geriatr Cardiol 11:287-94. 2002..3; 95% CI, 0.34, 4.9). ACE inhibitor use in the Kansas Medicaid congestive heart failure population is not consistent with practice guidelines, particularly among older and/or nursing home patients...
- Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insuranceKaren E Moeller
University of Kansas, School of Pharmacy, Department of Pharmacy Practice, Lawrence, KS, United States
Schizophr Res 126:117-23. 2011..The large rise in monitoring over time may be due to increase awareness of metabolic concerns by mental health care specialists, whom patients with schizophrenia are likely to receive their care from...
- Medicaid managed care: issues for beneficiaries with disabilitiesJean P Hall
Institute for Health and Disability Policy Studies, University of Kansas, 1122 West Campus Rd, Room 517, Lawrence, KS 66045, USA Department of Health Policy and Management, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mailstop 3044, 5001 Student Center, Kansas City, KS 66160, USA Electronic address
Disabil Health J 8:130-5. 2015..Now, however, some states are also moving this population to managed care. Little is known about the experiences of people with disabilities during and after this transition...
- Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiariesSally K Rigler
Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
Am J Geriatr Pharmacother 5:91-9. 2007..The availability of long-acting (LA) opioid medications represents an advance in the treatment of persistent pain, raising the question of what factors predict receipt of this newer treatment approach...
- Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysisCoraLynn B Trewet
University of Iowa, College of Pharmacy and Broadlawns Family Health Center, Des Moines, Iowa, USA
Drugs Aging 24:945-55. 2007..Some observational studies have also demonstrated reductions in hospitalisation but are potentially affected by non-random treatment selection...
- Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohortTheresa I Shireman
Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
Am J Geriatr Pharmacother 4:210-8. 2006..Cyclooxygenase-2-selective inhibitors (coxibs) have been widely adopted, despite study findings suggesting that they are cost-effective only in certain populations...
- High-risk teen compliance with prescription contraception: an analysis of Ohio Medicaid claimsTherese M Zink
Department of Family Medicine, University of Cincinnati, Cincinnati, OH 45267 0582, USA
J Pediatr Adolesc Gynecol 15:15-21. 2002..This study examines utilization of and compliance with prescription contraception by adolescents...
- Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychoticsKaren E Moeller
Departments of Pharmacy Practice, University of Kansas Medical Center, Kansas City 66160, USA
J Clin Psychiatry 67:1942-7. 2006..The primary objective of this study was to compare relapse rates among patients with schizophrenia who were switched to aripiprazole with those who switched to a second-generation antipsychotic (SGA) from another antipsychotic...
- Development of a contemporary bleeding risk model for elderly warfarin recipientsTheresa I Shireman
Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS 66160, USA
Chest 130:1390-6. 2006..Develop and validate a contemporary bleeding risk model to guide the clinical use of warfarin in the elderly atrial fibrillation (AF) population...
- Comparison of the association between disease burden and inappropriate medication use across three cohorts of older adultsSally K Rigler
Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA
Am J Geriatr Pharmacother 2:239-47. 2004..Frail elderly (FE) adults who are nursing home eligible but are receiving home- and community-based services (HCBS) constitute a distinct group sharing a high disease burden and high levels of medication use with the NF population...